Sign In
Buy ATNF
$7.04
+0 (+0%)
At Close: Nov 14, 2025
Elicit Plant nomme Pam Marrone et Johan de Saegher à son Conseil d’administration
05:30am, Wednesday, 01'st Mar 2023
MOULINS-SUR-TARDOIRE, France--(BUSINESS WIRE)--Elicit Plant, une agri-biotech spécialisée dans la résistance des plantes au stress hydrique qui développe une plateforme technologique à base de ph
Elicit Plant Appoints Pam Marrone and Johan de Saegher on Its Board of Directors
05:30am, Wednesday, 01'st Mar 2023
MOULINS-SUR-TARDOIRE, France--(BUSINESS WIRE)--Elicit Plant, an agricultural biotechnology company specialized in crops’ resistance to water stress based on a phytosterol-based technology platform,
Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)
01:56pm, Tuesday, 10'th Jan 2023
NEW YORK--(BUSINESS WIRE)--Newman Ferrara LLP announced today that it has an ongoing investigation into actions taken by officers and directors of KBL Merger Corp. IV (“KBL”), a special purpose ac
Using News to Find Penny Stocks to Buy: 3 Tips
06:00am, Monday, 09'th Jan 2023
Are you using the news to find penny stocks to buy? The post Using News to Find Penny Stocks to Buy: 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch
12:27pm, Friday, 06'th Jan 2023
Short squeeze penny stocks to watch this week. The post Penny Stocks To Buy This Week?
3 Essential Strategies for Penny Stocks Trading in 2023
11:00am, Saturday, 31'st Dec 2022
Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
The 7 Most Sold-Off Stocks of 2022
04:27pm, Saturday, 24'th Dec 2022
With a contentious time in 2022 coming to a close, it may be helpful to look back and consider the most sold-off stocks last year. Similar to learning from prior mistakes, investors may be able to gar
180 Life Sciences (ATNF) Stock: 1-For-20 Reverse Split Goes Into Effect
08:43am, Monday, 19'th Dec 2022
A 1-for-20 reverse split of 180 Life Sciences (ATNF) stock has gone into effect. These are the details.
180 Life Sciences Corp. Issues Letter to Stockholders
08:05pm, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.
PALO ALTO, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the "Company"), a clinical-stage biotechnology company today released the foll
Why 180 Life Sciences Shares Are Plunging Today
08:28am, Wednesday, 15'th Jun 2022
180 Life Sciences Corp (NASDAQ: ATNF) received a written response from the U.K.'s regulatory agency and U.S. FDA related to questions submitted in a Type C meeting request for anti-TNF treatment, a
180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease
08:15pm, Tuesday, 14'th Jun 2022 GlobeNewswire Inc.
PALO ALTO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the deve
180 Life Sciences Begins Consultations with UK and US Regulatory Authorities on Pathway for a Therapy that Could Prevent Progression of Early-Stage Dupuytren’s Disease
12:30pm, Tuesday, 31'st May 2022 GlobeNewswire Inc.
PALO ALTO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the devel
If You Invested $10,000 in Tesla in 2010, This Is How Much You Would Have Today
02:55pm, Friday, 27'th May 2022 The Motley Fool
Believing in electric vehicles back then would have made you very wealthy indeed.
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
02:07pm, Monday, 09'th May 2022 Benzinga
Upgrades
For Axogen Inc (NASDAQ:AXGN), Canaccord Genuity upgraded the previous rating of Hold to Buy. Axogen earned $0.20 in the first quarter, compared to $0.08 in the year-ago quarter. The stock has
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren’s Disease Study Results in The Lancet Rheumatology
10:32pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
PALO ALTO, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the dev
